Brief: Bayer And Iambic Collaborate To Advance Drug Discovery With AI
BRIEF-Bayer And Iambic Collaborate To Advance Drug Discovery With AI June 22 (Reuters) - BAYER AG BAYGn.DE:
BAYER AG - BAYER AND IAMBIC COLLABORATE TO ADVANCE DRUG DISCOVERY WITH AI
BAYER AG - COLLABORATION FOCUSES ON SMALL MOLECULE DISCOVERY
BAYER AG - UNDER TERMS OF AGREEMENT, IAMBIC WILL RECEIVE AN UPFRONT PAYMENT AS WELL AS MILESTONE AND ROYALTY PAYMENTS
Source text: ID:nBw2Qk8bFa
Further company coverage: [BAYGn.DE]
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bayer AG
See all newsBrief: Bayer Says Finerenone Slowed Kidney Decline In CKD
Insight: How cheap Chinese antibiotics threaten Europe's last major penicillin plant
Deutsche Bank AG FF - Post Stabilisation Notice -Bayer EUR 30NC6 & 30NC9
Brief: Bayer To Present New Finerenone Data Across Chronic Kidney Disease With And Without Diabetes At Asn Kidney Week 2026
Brief: FDA Approves Once-Weekly Generic Hormone Therapy Patch For Women